Le Lézard2h
China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Clene’s (CLNN) Buy Rating Reiterated at D. Boral Capital
Clene (NASDAQ:CLNN – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at D. Boral Capital in a note issued to investors on Wednesday,Benzinga reports. They currently have ...
Clinical Pain Advisor21h
OKYO Pharma Seeks Fast Track for Urcosimod in Neuropathic Corneal Pain
OKYO Pharma has filed a Fast Track designation application for urcosimod in the treatment of neuropathic corneal pain.
Optometry Advisor21h
Obstructive Sleep Apnea Risk Directly Correlates With Normal Tension Glaucoma Risk
Patients at a high risk for obstructive sleep apnea appear to have a stronger likelihood of also having normal tension glaucoma.